ABSTRACT
Las lesiones quísticas localizadas en la línea media de la glándula prostética presentan una incidencia difícil de estimar, debido a que la mayoría son asintomáticas y suelen ser un hallazgo casual durante el estudio de otra patología urológica. Presentamos el caso de un varón de 85 años que en el transcurso de un episodio de retención aguda de orina es diagnosticado de un quiste de retención prostético, y realizamos una revisión de la literatura.
The incidence of medial prostatic cysts is unknown, since most of them are asymptomatic, and usually appear as an incidental finding during the study of other urological disease. We report an 85 years oíd man with a urinary obstruction. Rectal palpation disclosed a mass that was adjacent to the prostate. Magnetic resonance showed a cystic lesión of the right seminal vesicle. The cyst was drained, obtaining 250 mi of fluid and urinary obstruction subsided. After three months of follow up, the patient remains asymptomatic.
Subject(s)
Humans , Male , Aged, 80 and over , Prostatic Diseases/surgery , Prostatic Diseases/diagnosis , Cysts/surgery , Cysts/diagnosis , Urinary Retention/etiology , Prostatic Diseases/complications , Cysts/complicationsABSTRACT
In the present study, we evaluated the seroprevalence of HTLV-I/II infection among the blood donors in Santa Fe and Santiago del Estero provinces. A total of 1327 serum samples from blood donors from Rafaela blood bank of Santa Fe province and 3382 serum samples from blood donors from Dr Edgar Bouzon blood bank of Santiago del Estero province were studied. The antibody screening was done by particle agglutination assay (PA) (SERODIA, Fujirebio Inc., Tokyo, Japan) or by enzyme immuno assay (EIA) (Abbott HTLV-I/HTLV-II EIA, Abbott, Germany). The "in house" indirect immunofluorescence assay (IFA) and Western blot (Bioblot HTLV Biokit, Barcelona, Spain) were used as confirmatory assays. All the samples resulted negative for specific antibodies against HTLV-I/II. These results suggest that HTLV-I/II are not circulating in low risk populations in these provinces or that the prevalences of infection would be lower than that reported by blood banks in other provinces of Argentina.
Subject(s)
Adult , Female , Humans , Male , Blood Donors , HTLV-I Infections/epidemiology , HTLV-II Infections/epidemiology , Argentina , Blood Banks , HTLV-I Antibodies , HTLV-II Antibodies , Prevalence , Risk , Seroepidemiologic StudiesABSTRACT
In this study we have determined the seroprevalence of infections by HTLV-I/II in the blood donor population from the city of Córdoba. A total of 5476 blood donor sera were screened for HTLV-I/II antibodies by particle agglutination assay (PA) (SERODIA HTLV-I, Fujirebio INC, Tokyo, Japan). The reactive sera samples were confirmed by an "in house" indirect immunofluorescence assay (IFA). 14 out of 5476 blood donors studied were PA reactive and were confirmed positive by IFA, showing a prevalence of 0.26 (95 confidence interval: 0.126-0.394). All the positive samples, except one, met the criteria for HTLV-I. Although one HTLV-I infected donor was an intravenous drug abuser and two donors were born in highly endemic areas for HTLV-I, no specific risk factors were identified among the others. The demonstration that HTLV-I circulates in blood donor population of Córdoba, points out that the systematic screening of blood for HTLV-I/II antibodies must be implemented in the blood banks, in an attempt to prevent the spread of infections with this oncogenic virus in Argentina.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Blood Donors , HTLV-I Antibodies , HTLV-II Antibodies , HTLV-I Infections/epidemiology , HTLV-II Infections/epidemiology , Substance Abuse, Intravenous/epidemiology , Argentina , Comorbidity , Mass Screening , Risk Factors , Seroepidemiologic Studies , Blood Transfusion/adverse effects , Blood Transfusion/statistics & numerical dataABSTRACT
In order to assess the efficiency of currently used screening tests, Abbott HTLV-I/HTLV-II EIA, Vironostika HTLV-I/II Organon Teknika, Particle Agglutination (PA) assay Serodia Fujirebio Inc. (Tokyo, Japan) for HTLV-I/II antibody detection in blood donors samples, a panel of 100 sera from different blood banks of Córdoba city were studied. An "in house" indirect immunofluorescence assay (IFA) was used as reference test. The correlation rates were: 66 for Abbott HTLV-I/HTLV-II EIA, 97 for Vironostika HTLV-I/II Organon Teknika EIA and 99 for PA Serodia. Vironostika HTLV-I/II Organon Teknika EIA and PA Serodia assay proved to be more reliable for HTlV-I/II antibody screening in blood donors from Córdoba, yielding a very low rate of false positive results as compared with Abbot HTLV-I/HTLV-II EIA.
Subject(s)
Humans , Blood Banks , HTLV-I Antibodies , HTLV-II Antibodies , Reagent Kits, Diagnostic , Argentina , HTLV-I Antibodies , HTLV-II Antibodies , Sensitivity and SpecificityABSTRACT
Se analiza el metodo utilizado en la determinacion del hidrogeno en aire expirado utilizando el micro lizador Quintron modelo No. 12, el valor diagnostico de la prueba en afecciones digestivas que cursan con intolerancia a carbohidratos con o sin esteatorrea, cuadros de contaminacion intestinal y dolor abdominal recurrente corrobado con casos clinicos